Constantí Serrallonga
Directeur/Membre du Conseil chez Archivel Farma SL
Postes actifs de Constantí Serrallonga
Sociétés | Poste | Début | Fin |
---|---|---|---|
Archivel Farma SL
Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Directeur/Membre du Conseil | 07/09/2011 | - |
Historique de carrière de Constantí Serrallonga
Formation de Constantí Serrallonga
University of Barcelona | Undergraduate Degree |
Statistiques
Internationale
Espagne | 3 |
Opérationnelle
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sectorielle
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Archivel Farma SL
Archivel Farma SL Miscellaneous Commercial ServicesCommercial Services Archivel Farma SL provides research and development services to the pharmaceutical sector. It focuses on TB, more specifically, on the treatment of the latent TB infection diseases. The firm is association with the Germans Trias i Pujol Research Institut of Health Sciences and the Germans Trias i Pujol University Hospital has developed RUTI, the first therapeutic vaccine against TB. The company was founded in 2005 by José Martínez, Pere-Joan Cardona i Iglèsias, Jaume Amat i Reira and Isabel Amat i Riera and is headquartered in Badalona, Spain. | Commercial Services |
- Bourse
- Insiders
- Constantí Serrallonga
- Expérience